1. Home
  2. DINO vs CYTK Comparison

DINO vs CYTK Comparison

Compare DINO & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Sinclair Corporation

DINO

HF Sinclair Corporation

N/A

Current Price

$53.09

Market Cap

10.2B

Sector

Energy

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$63.90

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DINO
CYTK
Founded
1947
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
7.6B
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
DINO
CYTK
Price
$53.09
$63.90
Analyst Decision
Buy
Strong Buy
Analyst Count
12
18
Target Price
$58.00
$87.56
AVG Volume (30 Days)
3.4M
1.7M
Earning Date
05-21-2026
05-25-2026
Dividend Yield
3.56%
N/A
EPS Growth
238.46
N/A
EPS
3.08
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$0.07
$9.79
Revenue Next Year
$1.73
$302.66
P/E Ratio
$18.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.66
$29.31
52 Week High
$59.33
$70.98

Technical Indicators

Market Signals
Indicator
DINO
CYTK
Relative Strength Index (RSI) 49.40 50.66
Support Level $47.04 $59.25
Resistance Level $53.77 $65.93
Average True Range (ATR) 2.40 2.54
MACD 0.03 -0.34
Stochastic Oscillator 50.92 41.35

Price Performance

Historical Comparison
DINO
CYTK

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: